Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
4293
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P03379 (Created: 1986-07-21 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
ENV_VILV
Protein Name
Envelope glycoprotein gp160
Gene
env
Organism Scientific
Maedi visna virus (strain 1514)
Organism Common
MVV
Lineage
Viruses
Retro-transcribing viruses
Retroviridae
Orthoretrovirinae
Lentivirus
Ovine/caprine lentivirus group
Protein Length [aa]
982
Protein Mass [Da]
113978
Features
Type
Description
Status
Start
End
signal peptide
potential
1
106
chain
Envelope glycoprotein gp160
107
982
chain
Surface protein
by similarity
107
656
chain
Transmembrane protein
by similarity
657
982
transmembrane region
potential
832
852
topological domain
Extracellular
potential
107
831
topological domain
Cytoplasmic
potential
853
982
region of interest
Fusion peptide
657
677
region of interest
Immunosuppression
by similarity
723
738
glycosylation site
N-linked (GlcNAc...)
potential
140
140
glycosylation site
N-linked (GlcNAc...)
potential
161
161
glycosylation site
N-linked (GlcNAc...)
potential
206
206
glycosylation site
N-linked (GlcNAc...)
potential
258
258
glycosylation site
N-linked (GlcNAc...)
potential
298
298
glycosylation site
N-linked (GlcNAc...)
potential
364
364
glycosylation site
N-linked (GlcNAc...)
potential
370
370
glycosylation site
N-linked (GlcNAc...)
potential
381
381
glycosylation site
N-linked (GlcNAc...)
potential
387
387
glycosylation site
N-linked (GlcNAc...)
potential
403
403
glycosylation site
N-linked (GlcNAc...)
potential
414
414
glycosylation site
N-linked (GlcNAc...)
potential
435
435
glycosylation site
N-linked (GlcNAc...)
potential
439
439
glycosylation site
N-linked (GlcNAc...)
potential
470
470
glycosylation site
N-linked (GlcNAc...)
potential
475
475
glycosylation site
N-linked (GlcNAc...)
potential
481
481
glycosylation site
N-linked (GlcNAc...)
potential
491
491
glycosylation site
N-linked (GlcNAc...)
potential
501
501
glycosylation site
N-linked (GlcNAc...)
potential
515
515
glycosylation site
N-linked (GlcNAc...)
potential
527
527
glycosylation site
N-linked (GlcNAc...)
potential
537
537
glycosylation site
N-linked (GlcNAc...)
potential
542
542
glycosylation site
N-linked (GlcNAc...)
potential
543
543
glycosylation site
N-linked (GlcNAc...)
potential
568
568
glycosylation site
N-linked (GlcNAc...)
potential
697
697
glycosylation site
N-linked (GlcNAc...)
potential
764
764
glycosylation site
N-linked (GlcNAc...)
potential
771
771
glycosylation site
N-linked (GlcNAc...)
potential
787
787
glycosylation site
N-linked (GlcNAc...)
potential
821
821
site
Cleavage; by host
by similarity
656
657
compositionally biased region
Poly-Lys
958
961
lipid moiety-binding region
S-palmitoyl cysteine; by host
by similarity
855
855
coiled-coil region
potential
689
738
coiled-coil region
potential
779
814
SP Length
106
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MASKESKPSRTTWRDMEPPLRETWNQVLQELVKRQQQEEEEQQGLVSGKK
KSWVSIDLLGTEGKDIKKVNIWEPCEKWFAQVVWGVLWVLQIVLWGCLMW
EVRKGN
Sequence
MASKESKPSRTTWRDMEPPLRETWNQVLQELVKRQQQEEEEQQGLVSGKK
KSWVSIDLLGTEGKDIKKVNIWEPCEKWFAQVVWGVLWVLQIVLWGCLMW
EVRKGN
QCQAEEVIALVSDPGGFQRVQHVETVPVTCVTK
N
FTQWGCQPEG
AYPDPELEYR
N
ISREILEEVYKQDWPWNTYHWPLWQMENMRQWMKENEKE
YKERT
N
KTKEDIDDLVAGRIRGRFCVPYPYALLRCEEWCWYPESINQETG
HAEKIKI
N
CTKAKAVSCTEKMPLAAVQRVYWEKEDEESMKFLNIKAC
N
IS
LRCQDEGKSPGGCVQGYPIPKGAEIIPEAMKYLRGKKSRYGGIKDKNGEL
KLPLSVRVWVRMA
N
LSGWV
N
GTPPYWSARI
N
GSTGI
N
GTRWYGVGTLHHL
GY
N
ISSNPEGGIC
N
FTGELWIGGDRFPYYYKPSW
N
CSQ
N
WTGHPVWHVFR
YLDMTEHMTSRCIQRPKRH
N
ITVG
N
GTITG
N
CSVTNWDGC
N
CTRSGNHLY
N
STSGGLLVIICRQ
N
STITGIMGTNT
N
WTTMWNIYQ
N
CSRC
N
N
SSLDRTG
SGTLGTVNNLKCSLPHR
N
ESNKWTCKSQRDSYIAGRDFWGKVKAKYSCES
NLGGLDSMMHQQMLLQRYQVIRVRAYTYGVVEMPQSYMEERGENRRSRRN
LQRKK
RG
IGLVIVLAIMAIIAAAGAGL
GVANAVQQSYT
RTAVQSLANATA
AQQEVLEASYAMVQHIAKGIRILEARVARVEALVDMMV
YQELDCWHYQHY
CVTSTRSEVANYV
N
WTRFKD
N
CTWQQWE
EEIEQHEGNLSLLLREAALQVH
IAQRDARRIPDAWK
AIQEAF
N
WSSWFSWLKY
IPWIIMGIVGLMCFRILMC
VI
SM
C
LQAYKQVKQIRYTQVTVVIEAPVELEEKQKRNGDGTNGCASLEHE
RRTSHRSFIQIWRATWWAWKTSPWRHNWRTMPYITLLPILVIWQWMEENG
WNGENQH
KKKK
ERVDCQDREQMPTLENDYVEL
Original
MASKESKPSRTTWRDMEPPLRETWNQVLQELVKRQQQEEEEQQGLVSGKK
KSWVSIDLLGTEGKDIKKVNIWEPCEKWFAQVVWGVLWVLQIVLWGCLMW
EVRKGNQCQAEEVIALVSDPGGFQRVQHVETVPVTCVTKNFTQWGCQPEG
AYPDPELEYRNISREILEEVYKQDWPWNTYHWPLWQMENMRQWMKENEKE
YKERTNKTKEDIDDLVAGRIRGRFCVPYPYALLRCEEWCWYPESINQETG
HAEKIKINCTKAKAVSCTEKMPLAAVQRVYWEKEDEESMKFLNIKACNIS
LRCQDEGKSPGGCVQGYPIPKGAEIIPEAMKYLRGKKSRYGGIKDKNGEL
KLPLSVRVWVRMANLSGWVNGTPPYWSARINGSTGINGTRWYGVGTLHHL
GYNISSNPEGGICNFTGELWIGGDRFPYYYKPSWNCSQNWTGHPVWHVFR
YLDMTEHMTSRCIQRPKRHNITVGNGTITGNCSVTNWDGCNCTRSGNHLY
NSTSGGLLVIICRQNSTITGIMGTNTNWTTMWNIYQNCSRCNNSSLDRTG
SGTLGTVNNLKCSLPHRNESNKWTCKSQRDSYIAGRDFWGKVKAKYSCES
NLGGLDSMMHQQMLLQRYQVIRVRAYTYGVVEMPQSYMEERGENRRSRRN
LQRKKRGIGLVIVLAIMAIIAAAGAGLGVANAVQQSYTRTAVQSLANATA
AQQEVLEASYAMVQHIAKGIRILEARVARVEALVDMMVYQELDCWHYQHY
CVTSTRSEVANYVNWTRFKDNCTWQQWEEEIEQHEGNLSLLLREAALQVH
IAQRDARRIPDAWKAIQEAFNWSSWFSWLKYIPWIIMGIVGLMCFRILMC
VISMCLQAYKQVKQIRYTQVTVVIEAPVELEEKQKRNGDGTNGCASLEHE
RRTSHRSFIQIWRATWWAWKTSPWRHNWRTMPYITLLPILVIWQWMEENG
WNGENQHKKKKERVDCQDREQMPTLENDYVEL
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11